key: cord-0840316-538r5ybo
authors: Loss, M.; Katchen, M.; Arvelo, I.; Arnold, P.; Shum, M.
title: COVID-19 Implications of the Physical Interaction of Artificial Fog on Respiratory Aerosols
date: 2021-03-20
journal: nan
DOI: 10.1101/2021.03.18.21253891
sha: ce736bd13bd92112ee4b618ab8a77b0f5d082de8
doc_id: 840316
cord_uid: 538r5ybo

Introduction Artificial fog is used in the film, television, and live entertainment industries to enhance lighting, as a visual effect, and to create a specific sense of mood or atmosphere. This study investigated whether the suspension time of respiratory aerosols spiked with tagged DNA tracers would change in the presence of glycerin- or glycol-containing artificial fogs. Methods & Materials Respiratory aerosols with tagged DNA tracers were sprayed into a closed environment without and with glycerin- or glycol-containing artificial fog, with air samples taken at regular intervals to determine the decay of tagged DNA tracer over time. The study treatments included Control (no fog), Glycerin Low (3 mg/m3), Glycerin High (~15 mg/m3), Glycol Low (~5 mg/m3), and Glycol High (~40 mg/m3). Results All artificial fog treatments had lower mean log reduction curves compared to the Control treatment. Compared to the Control and Glycerin Low treatments, the differences in mean log reduction for nearly all other artificial fog treatments were statistically significant (p<0.001); the difference between Control and Glycerin Low treatments was not statistically significant (p=0.087). The differences in mean log reduction between treatments using the same artificial fog type were not statistically significant. Conclusion Artificial fog use does not increase suspension time of respiratory aerosols, and therefore does not appear to increase the risk of airborne transmission of diseases from respiratory aerosols, such as COVID-19. Of the two types of artificial fogs investigated, that containing glycol decreased suspension time more than that containing glycerin. In practice, the additional reduction in suspension time provided by the physical interaction of respiratory aerosols with artificial fog does not suggest any practical benefit for using artificial fog as a control measure.

Respiratory aerosols with tagged DNA tracers were sprayed into a closed environment with and 88 without artificial fog, where air samples of aerosols were taken at regular intervals to determine 89 the decay of tagged DNA tracer over time. A small office boardroom measuring 545 cubic feet 90 (8'11" long by 8' 4" wide by 7' 5" high), occupied with one table and two chairs, was sealed along 91 the walls, door, window, supply air diffuser, and ceiling with one millimeter-thick poly sheeting 92 (HDX, Canada). This poly sheeting created a closed environment where airflow in or out of the 93 room was minimized, thereby limiting tagged DNA tracer decay due to natural settling processes 94

only. Five treatments were completed: one control treatment, two glycerin-containing artificial fog 95 treatments, and two glycol-containing artificial fog treatments. The two glycerin-containing 96 artificial fog treatments aimed to maintain airborne glycerin concentrations at approximately 1.5 97 milligrams per cubic meter (mg/m 3 ) or 15 mg/m 3 ; the two glycol-containing artificial fog treatments 98 aimed to maintain airborne glycol concentrations at approximately 5 mg/m 3 or 40 mg/m 3 . These 99 glycerin and glycol concentrations aligned with regulatory or guideline limits commonly used for 100 workplaces in North America (i.e., for 12-hour time-weighted average and ceiling limits, 101 respectively). For each treatment, six trials were completed; each trial consisted of spraying a 102 unique tagged DNA tracer into the room and collecting one five-minute sample every five minutes 103 from the time of spray until thirty-minutes had elapsed, for a total of six samples collected per trial 104 and 36 samples per treatment. The cowl was angled downward at approximately 45 degrees and suspended approximately five 116 feet above the ground in the middle of the room by an aluminum tripod (Environmental Monitoring  117 Systems, USA). The cassette angle helped minimize collection of aerosols through deposition 118 and mimicked the human nose more accurately when used in conjunction with the cowl. Once 119 the first sample was ready, the tagged DNA tracer fluid was sprayed five times from a Flairosol 120 spray bottle, distributing the aerosols into each corner and center of the room; the different 121 directions of each spray assisted in homogenizing the aerosol in the room quickly. Immediately 122 after spraying, the Leland Legacy Pump was turned on to begin the first sample; the first sample 123 started after the sprays owing to Researcher limitations . Once this first sample started, a table  124 fan with a blade diameter of twelve inches (GD Midea Environment Appliance Mfg. Co., Ltd, 125

China) located in the Southeast corner was turned on to its lowest speed (660 feet per minute 126 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. The number of DNA copies aerosolized were calculated and adjusted based on the concentration 219 of DNA measured in each bulk liquid sample (Equation 1). This value was also adjusted based 220 on an aerosol fraction, which synchronizes the Flairosol spray bottle aerosol fraction to that 221 generated from sneezing, talking, and coughing. Given the described distribution of aerosol sizes 222 generated from sneezing, talking, and coughing, and the potential for partial or total evaporation 223 of liquid aerosols between 60 to 100 µm ( The logarithmic (log) reduction was calculated for each sample using base ten (Equation 2). In 235 addition to log reduction, the number of copies per million copies aerosolized was calculated for 236 each sample (Equation 3 ). 237 238 10 = 10 ( / ) (Eq. 2) 239 240 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The assumption of normality for the treatments was qualitatively assessed, because the sample 268

size was too small for formal statistical tests. The assumption of homogeneity of variance was 269 tested using a Bartlett Test of Homogeneity of Variance (Bartlett, 1937) , applied to the combined 270 levels of the variables "Treatment -Interval". A two-way analysis of variance (ANOVA) (Chambers 271 & Hastie, 1992) was performed with the levels of the variables "Treatment" and "Interval" to 272 determine if there was any significant interaction between the two variables. An ANOVA and 273

Tukey Honest Significant Differences test (Miller, 1981; Yandell, 1997) Sampling was completed between November 2020 and January 2021 in Burnaby, British 283

Columbia, Canada. All treatments were completed by the same Researcher, in the same office 284 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.18.21253891 doi: medRxiv preprint space, under similar environmental conditions. The maximum mean difference in temperature 285 and relative humidity between treatments was 3.6°C and 12.4%. Two trials were excluded from 286 the analysis: one was a calibration trial to refine the methodology (Glycerin Low, Trial 1) and the 287 other was analyzed for the incorrectly tagged DNA tracer (Glycol Low, Trial 3). Nearly all 288 treatments with artificial fog maintained glycerin or glycol concentrations near the desired 289 concentration. One exception is the Glycerin Low treatment, where the glycerin concentration was 290 higher (Table 1) Notes. mg/m 3 = milligrams per cubic meter, * Trial #1 was a calibration trial to refine the methodology and was removed 294 as an outlier, ** Trial #3 was analyzed for the incorrect tagged DNA tracer and was removed 295 296 3.2 Suspension Time 297 298

All artificial fog treatments had lower mean log reduction curves compared to the Control 299 treatment, indicating the tagged DNA tracers in air decayed at a faster rate, and their suspension 300 time in air was shorter (Figure 2 ). The Glycol High mean log reduction curve was the lowest, with 301 the shortest suspension time of tagged DNA tracers in air. The glycol-containing fog treatments 302 had lower mean log reduction curves compared to the glycerin-containing fog treatments. The 303

Glycerin High mean log reduction curve was lower than the Glycerin Low mean log reduction 304

curve. 305 306

The overall mean log reduction, from the time of spray until 30 minutes had elapsed, ranged from 307 6.4 logs for the Control treatment to 7.5 logs for the Glycol High treatment. Within the first and 308 last measured sampling times (intervals), the total log reduction measured for the Control 309 treatment was 2.6 logs. The artificial fog treatments resulted in reductions ranging from 2.8 to 3.4 310 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.18.21253891 doi: medRxiv preprint logs, with Glycol High yielding the largest overall log reduction. In general, with each successive 311 sampling interval, the magnitude of reduction decreased for all treatments. The largest mean log 312 reductions for all treatments occurred during the first three sampling times, which were the first 313 15 minutes after spraying. Between 15 to 30 minutes, the total mean log reduction was 1.1 logs 314 or less for all treatments. 315 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. log reduction (mean ± 95% CI) was calculated and plotted at each sampling time (interval). The solid point represents the mean and 317 the bar and whiskers represent the 95% confidence interval around the mean. Within a treatment panel, the colored line represents 318 that treatment's mean log reduction curve while the grey curves represent all other treatment mean log reduction curves. 319

Given the sample size, no formal statistical test was applied to test the assumption of normality 320

for the log reductions. Based on a qualitative assessment of the individual data points, the data 321 follows a central trend; therefore, this assumption is moderately accurate. The test for 322 homogeneity of variance applied to the combined levels of the variables "Treatment-Interval" 323 yielded no statistically significant differences (p = 0.11, K-squared = 38.37). The two-way ANOVA 324 determined the interaction between the variables "Treatment" and "Interval" was not statistically 325 significant (p = 0.633), indicating that there is no interaction between the variables, and their 326 effects on mean log reduction are independent of each other. When analyzed independently, the 327 effect of "Treatment" was statistically significant (p<0.001), and the effect of "Interval" was also 328 statistically significant (p<0.001). 329 330

Compared to the Control and Glycerin Low treatments, the differences in mean log reduction for 331 nearly all other artificial fog treatments were statistically significant (p<0.001) ( Table 2 ). The 332 difference in mean log reduction between Control and Glycerin Low treatments was not 333 statistically significant (p = 0.087). The differences in mean log reduction between treatments 334 using the same artificial fog type were not statistically significant. 335 336 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 20, 2021. Notes. * statistically significant, CI = confidence interval 338 339

The differences in mean log reduction between nearly each sampling time were statistically 340 significant (p<0.05); the exception is between sampling times "20 to 25" and "25 to 30", where the 341 difference in mean log reduction was not statistically significant (p = 0.18). 342 343 4 Discussion 344 345

It was shown that artificial fog appears to decrease suspension time to varying degrees depending 346 on the chemical composition and airborne concentration. The largest decrease in suspension time 347

was observed after the first five minutes, where all treatments had at least a four-log reduction. 348

The log reduction observed in the artificial fog treatments was, in general, statistically significant 349 compared to the Control treatment. The magnitude of reduction past four logs became 350 exponentially smaller with each additional log reduction. A change from four to five logs is 351 equivalent to a reduction of an additional 0.009%, and a change from five to six logs is equivalent 352 to a reduction of an additional 0.0009%. Although artificial fog treatments were observed to have 353 lower mean reduction curves, the amount of additional reduction yielded from the physical 354 interaction of artificial fogs does not appear to be practically significant as a control measure for 355 reducing airborne aerosols. 356 357

The natural decay of artificial fog in air was semi-quantitatively assessed by bringing up fog levels 358

to both high and low levels and observing the decay with the pDR-1000AN Monitor. To decay 359 90% from a starting concentration that matched the "High" treatment, it took the glycerin-360

containing artificial fog approximately one hour and seventeen minutes and the glycol-containing 361

artificial fog approximately ten minutes. The presence of the tagged DNA tracer in air did not 362 appear to drastically alter this decay duration. The intended use of these two artificial fogs were 363 different, where the glycerin-containing artificial fog was designed to stay suspended in air to 364 create a haze effect, while the glycol-containing artificial fog was designed to be a low-lying fog. 365

The different purposes of each artificial fog may have contributed to their effect on respiratory 366 aerosol suspension time. If the artificial fog physically interacts with respiratory aerosols, artificial 367

fogs that are designed to fall more quickly out of air, or be low-lying, may physically remove 368 respiratory aerosols and shorten suspension time compared to artificial fogs designed to remain 369 in air longer. The opposite does not appear to be true, as the artificial fogs designed to stay in air 370 did not increase respiratory aerosol suspension time in air compared to no artificial fog. 371 372

The relative humidity during the Glycol High treatment had a mean difference of -12.4% compared 373

to the Control treatment, noticeably lower than the other artificial fog treatments. Lower relative 374 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) This study supports that artificial fog does not increase the suspension time of respiratory aerosols 406 in air, but rather has no effect or decreases the suspension time. Of the two types of artificial fogs 407 investigated, artificial fog containing glycol decreased suspension time more than that containing 408 glycerin. Regardless of the type of artificial fog used, suspension time decreased more with 409

increasing artificial fog concentration, albeit not statistically significantly. In practice, the additional 410 reduction in suspension time provided by the physical interaction of respiratory aerosols with 411 artificial fog does not suggest any practical benefit for using artificial fog as a control measure. 412

The principal outcome supported by this study was that artificial fog use does not increase 413 suspension time of respiratory aerosols, and therefore does not appear to increase the risk of 414 airborne transmission of diseases from respiratory aerosols, such as COVID-19. 415

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 20, 2021. ; https://doi.org/10.1101/2021.03.18.21253891 doi: medRxiv preprint

Properties of sufficiency and statistical tests

Statistical models in S

Some questions on dispersion of human exhaled droplets in 432 ventilation room: answers from numerical investigation

Calibration Factors for Monitoring Theatrical 435 Smoke and Haze. Prepared for Entertainment Services and Technology Association

Calibration Factors and Time-And-Distance 438

Guidelines for Use of Theatrical Fog Equipment: Aquamax with Organic Haze Fluid and 439 HazeMax with Water Vapour Haze Fluid

Microsoft Excel

Simultaneous Statistical Inference

R: A language and environment for statistical computing. R Foundation for 446 Statistical Computing

Aerosol persistence in relation to possible transmission of SARS-CoV-2

Welcome to the Tidyverse

How far droplets can move in 456 indoor environments-revisiting the Wells evaporation-falling curve

Exhaled droplets due to talking and coughing

Practical data analysis for designed experiments

COVID-19: effects of 464 environmental conditions on the propagation of respiratory droplets